FindTrial
Sign In

skin side effects of anticancer drugs in cancer patients

Cutaneous adverse effects of chemotherapy in cancer patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2013/10/004101
Enrollment
90
Registered
2013-10-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- cutaneous adverse effects of chemotherapy in cancer patients

Interventions

None listed

Sponsors

Dr Rachel Pavey
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)patients who give informed consent 2)patients of both sexes & age- 6 yrs & above 3)Patients willing to undergo necessary investigations if required

Exclusion criteria

Exclusion criteria: 1) Patients not willing for the study. 2)Patients having a primary skin disease. 3)Patients developing cutaneous manifestations as a result of internal malignancies & not on chemotherapy. 4)Patients on radiotherapy

Design outcomes

Primary

MeasureTime frame
To describe the cutaneous adverse effects of chemotherapy & also its frequency severity & distribution in cancer patients Timepoint: 1 year—

Secondary

MeasureTime frame
To describe the cutaneous adverse effects of chemotherapy & also its frequency severity & distribution in cancer patients Timepoint: 1 year—

Countries

India

Contacts

Public ContactDr Rachel Pavey

Father Muller Medical College

srinath76@yahoo.co.in9886395249

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026